not tagged
Mustang Bio
['nhl', 'cll']
a multicenter phase 1/2 #clinicaltrial evaluating the safety and efficacy of mb-106 for relapsed or refractory b-nhl and cll under mustang s ind is open for enrollment and details can be found here. #eha2022 $mbio 
Mustang Bio, a Fortress Biotech company, is focused on the development of novel immunotherapies and gene therapies in areas of unmet need.